基于凝的创新治疗新生儿中风
Victor Mondal1, Emily Ross-Munro1, Kate Firipis2,3
1School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia (V.M., E.R.-M., G.K.B., R.K., M.M.H., D.W.W., M.T., B.F.).
Stroke
|May 22, 2025
概括
新生儿中风是一种严重影响新生儿的疾病,目前缺乏治疗脑损伤的有效方法. 这篇评论探讨了先进的水凝疗法如何有望在中风后的婴儿中修复脑损伤.
科学领域:
- 生物材料科学 生物材料科学
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
背景情况:
- 新生儿中风影响超过2500个新生儿中的1个,导致严重的残疾,如脑和.
- 新生儿中风的风险特别高,具有显著的长期临床和社会经济后果.
- 目前的医疗干预措施无法治疗新生儿中风引起的脑损伤.
研究的目的:
- 审查生物相容水凝在解决新生儿中风病理生理学的潜力.
- 探索水凝疗法用于修复新生儿中风中脑损伤的应用.
- 为改善严重脑损伤的婴儿的治疗结果提供水凝治疗的全面视角.
主要方法:
- 对生物相容水凝的当前知识的综合.
- 分析与组织修复相关的水凝特性 (可调节的弹性,刚性,剪切薄化).
- 在中枢神经系统损伤修复中对水凝应用的审查.
主要成果:
- 水凝提供可调节的特性,用于控制治疗剂的局部输送.
- 工程化水凝有可能解决新生儿中风的特定病理生理学问题.
- 水凝在修复成人中枢神经系统中严重的焦点病变方面已经证明有效.
结论:
- 生物相容的水凝代表了新生儿中风的有希望的治疗策略.
- 水凝治疗有可能改善脑损伤的婴儿的功能结果.
- 对尖端水凝疗法的进一步研究对于临床转化至关重要.
相关概念视频
Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


